Cochrane Abstracts
Artemisinin derivatives for treating severe malaria
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Artemisinin Derivatives for Treating Severe Malaria." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439412/all/Artemisinin_derivatives_for_treating_severe_malaria.
Artemisinin derivatives for treating severe malaria. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439412/all/Artemisinin_derivatives_for_treating_severe_malaria. Accessed March 1, 2025.
Artemisinin derivatives for treating severe malaria. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439412/all/Artemisinin_derivatives_for_treating_severe_malaria
Artemisinin Derivatives for Treating Severe Malaria [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439412/all/Artemisinin_derivatives_for_treating_severe_malaria.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Artemisinin derivatives for treating severe malaria
ID - 439412
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439412/all/Artemisinin_derivatives_for_treating_severe_malaria
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
